3JIANG Z,YOU DY,CHEN XC,et al.Monitoring of serum markers of fib-rosis during CCl4-induced liver damage-effects of antifibrotic agents[J].Hepatology,1992,16 (3):282-289.
10TSUKAMOTO H,REIDELBERGER RD,FRENCH SW,et al.Long term cannulation model for blood sampling and intragastric infusion in the rat[J].AmJ Physiol,1984,247 (3pt2):R595-599.
6[1]Nan J X, Park E J, Lee S H, et al. Antifibrotic effect of Stephania tetrandra on experimental liver fibrosis induced by bile duct ligation and scission in rats. Arch Pharm Res,2000, 23(5):501 - 506.
7[2]Suchuppan D, Strobel D, Hann E G. Hepatic fibrosis-therapeutic strategies. Digestion, 1998,59: 385.
8[3]Aronson D G, Chamuleau A F M, Frederiks W M, et al. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact of fantasy? J Hepatol, 1993,18:85.
9[4]Gamal A A,Guy L,Pescan P Y, et al. Reversibility of hepatic fibrosis in experimentally induced cholestssis in rat. Am J Pathol, 1990,137(6): 1333.
10[5]Arthur M J P. Collagenases and liver fibrosis. J Hepatol, 1995,22:43.
